Mesenchymal stem cells for treatment of myocardial infarction

International Journal of Stem Cells

Volumn 1, Issue 1, 2008, Pages 49-54

  Ko, Il Kwon ^a   Kim, Byung Soo ^a  

^a Hanyang University   (South Korea)

Author keywords

Cardiomyocyte; Differentiation; Mesenchymal stem cell; Myocardial infarction

Indexed keywords

EID: 80051582312     PISSN: 20053606     EISSN: 20055447     Source Type: Journal    
DOI: 10.15283/ijsc.2008.1.1.49     Document Type: Article

References (35)

1. Korean statistical information service (http://www.kosis.kr/domestic/theme/do01_index.jsp)
2. Yuyama ET, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone marrow cells: a pilot study and a randomised controlled trial. Lancet 2002;360:427-435
3. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Int J Hematol 2007;86:17-21
4. Tomita S, Ren KL, Richard DW, Donald AG, Mickle DA, Kim EJ, Sakai T, Jia JQ. Autologous transplantation of bone marrow sells improves damaged heart function. Circulation 1999;100[supplII]:II-247-II-256
5. Cottler-Fox MH, Lapidot T, Petit I, Kollet O, DiPersio JF, Link D, Devine S. Stem cell mobilization. Hematology Am Soc Hematol Educ Program 2003:419-437
6. Togel F, Westenfelder C. Adult bone marrow?derived stem cells for organ regeneration and repair. Dev Dyn 2007;236: 3321-3331
7. Ince H, Petzsch M, Kleine HD, Eckard H, Rehders T, Burska D, Kische S, Freund M, Nienaber CA. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by granulocyte colony-stimulating factor (FIRSTLINE-AMI) trial. Circulation 2005;112:I-73-I-80
8. Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet PA, Windecker S, Eberli FR, Meier B. Colony-stimulating factor in patients with coronary artery disease: A promotion of collateral growth by granulocyte-macrophage randomized, double-blind, placebo-controlled study. Circulation 2001;104: 2012-2017
9. Wollert K, Meyer G, Lotz J, Lichtenberg SR, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-148
10. Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM. Intracoronary bone marrow?derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355: 1210-1221
11. Breitbach M, Bostani T, Roell W, Xia Y, Dewald O, Nygren JM, Fries JWU, Tiemann K, Bohlen H, Hescheler J, Welz A, Bloch W, Jacobsen SEW, Fleischmann BK. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007;110:1362-1369
12. Yoon YS, Park JS, Tkebuchava T, Luedeman C, Losordo DW. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 2004;109:3154-3157
13. Kunter U, Rong S, Boor P, Eitner F, Newen GM, Djuric Z, Roeyen CR, Konieczny A, Ostendorf T, Villa L, Popovska MM, Kerjaschki D, Floege J. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol 2007; 18:1754-1764
14. Atsma DE, Fibbe WE, Rabelink TJ. Opportunities and challenges for mesenchymal stem cell-mediated heart repair. Curr Opin Lipidol 2007;18:645-649
15. Rubio D, Castro JG, Martín MC, Fuente R, Cigudosa JC, Lloyd AC, Bernad A. Spontaneous human adult stem cell transformation. Cancer Res 2005;65:3035-3039
16. Tolar J, Nauta AJ, Osborn MJ, Mortari AP. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 2007;25: 371-379
17. Tyndall A, Walker UA, Cope A, Dazzi F, Bari CD, Fibbe W, Guiducci S, Jones S, Jorgensen C, Blanc KL, Luyten F, McGonagle D, Martin I, Tyndall CB, Pennesi G, Pistoia V, Pitzalis C, Uccelli A, Wulffraat N, Feldmann M. Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther 2007;9:301
18. Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink FGA, Willemze R, Fibbe WE. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 2006;108:2114-2120
19. Ohnishi S, Ohgushi H, Kitamura S, Nagaya N. Mesenchymal stem cells for the treatment of heart failure. Int J Hematol 2007;86:17-21
20. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, Pittenger MF, Martin BJ. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 2002;73:1919-1925
21. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10:858-864
22. Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J, Taneera J, Fleischmann BK, Jacobsen SE. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not differentiation. Nat Med 2004;10:494-501
23. Noiseux N, Gnecchi M, Ilasaca ML, Zhang L, Solomon SD, Deb A, Dzau VJ, Pratt RE. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 2006;14:840-850
24. Wang XJ, Li QP. The roles of mesenchymal stem cells (MSCs) therapy in ischemic heart diseases. Biochem Biophy Res Comm 2007;359:189-193
25. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005;11:367-368
26. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2002;107:1395-1402
27. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999;103: 697-705
28. Antonitsis P, Papagiannaki EI, Kaidoglou A, Papakonstantinou C. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine. Interact Cardiovasc Thorac Surg 2007;6:593-597
29. VanWinkle WB, Snuggs MB, Buja LM. Cardiogel: a biosynthetic extracellular matrix for cardiomyocyte culture. In Vitro Cell Dev Biol Anim 1996;32:478-485
30. Huang NF, Lee RJ, Li S. Chemical and physical regulation of stem cells and progenitor cells: Potential for cardiovascular tissue engineering. Tissue Eng 2007;13:1809-1823
31. Yoon JY, Shim WJ, Ro YM, Lim DS. Transdifferentiation of mesenchymal stem cells into cardiomyocytes by direct cell-to-cell contact with neonatal cardiomyocyte but not adult cardiomyocytes. Ann Hematol 2005;84:715-721
32. Iijima Y, Nagai T, Mizukami M, Matsuura K, Ogura T, Wada H, Toko H, Akazawa H, Takano H, Nakaya H, Komuro I. Beating is necessary for transdifferentiation of skeletal muscle-derived cells into cardiomyocytes. FASEB J 2003;17:1361-1363
33. Itescu S, Schuster MD, Kocher AA. New directions in strategies using cell therapy for heart disease. J Mol Med 2003; 81:288-296
34. Xu W, Zhang X, Qian H, Zhu W, Sun X, Hu J, Zhou H, Chen YC. Mesenchymal stem cells from adult human bone marrow differentiates into a cardiomyocyte phenotype in vitro. Exp Biol Med 2004;229:623-631
35. Kim HS. Stem cell research for cardiovascular regeneration. Mol Cell Biol News 2005;17:31-40